The criminal trial of a New York man may help explain how tens of millions of dollars in illicit profits were allegedly generated by a global insider-trading network that included a Greek pharmaceutical executive, a
Telemaque Lavidas is the first of the accused to go before a jury in the U.S., where prosecutors say he was one of the people feeding information into a network of traders on several continents. His trial starts Monday in federal court.
In a scheme that stretched for ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.